IHH's proton therapy takes aim at tumours with precision and low risk

Leaving surrounding organs at risk during cancer treatment might become a thing of the past.

Proton therapy may allow oncologists to focus on tumors with surgical precision, possibly reducing complications and improving patient outcomes.

This technology is now being implemented at the new Mount Elizabeth Proton Therapy Centre, where doctors are beginning to utilize its minimally invasive precision to treat a range of complex and hard-to-treat cancers.

To ensure the treatment’s effectiveness, IHH Healthcare Singapore CEO Peter Chow touted the centre’s use of a compact singleroom Intensity Modulated Proton Therapy (IMPT) system called the Proteus®ONE solution.

“It also contains Ion Beam Applications’ latest Pencil Beam Scanning (PBS) technology to target tumours precisely with an accuracy level of +/=0.2mm, along with isocentre volumetric imaging (Cone Beam CT), and stereotactic x-ray imaging capabilities for more accurate patient positioning before starting treatment,” Chow said.